Pubblicazioni (scarica PDF) - Fondazione IRCCS

Lista delle pubblicazioni scientifiche su riviste nazionali e internazionali
* Con IMPACT FACTOR
1. V. VENTAFRIDDA, M. TAMBURINI, F. DE CONNO: Comprehensive treatment in cancer pain.
Advances in Pain Research and therapy. New York, Vol.9, 617- 628, 1985
2. V. VENTAFRIDDA, M. TAMBURINI, S. SELMI, L. VALERA, F. DE CONNO: The importance of a
home care program for patients with advanced cancer pain. Tumori, 71, 449-454, 1985
3. Ventafridda V., Spoldi E, Caraceni A, Tamburini M, De Conno F: The importance of continuous
subcutaneous morphine administration for cancer pain control. Pain Clinic 1: 47-55, 1986. (IF 0)
4. V. VENTAFRIDDA, F. DE CONNO, M. TAMBURINI, M. PAPPALETTERA: Clinical evaluation of
chronic infusion of intrathecal morphine in cancer pain. Advances in Pain Research and Therapy,
Vol. 8, 391-397, 1986
5. V. VENTAFRIDDA, M. TAMBURINI, S. SELMI, F. DE CONNO: Pain and quality of life assesment
in advanced cancer patients. In: Pain and quality of life assessment in advanced cancer patients
(Ventafridda, Van Dam, Yancik, Tamburini) Excerpta medica, Amsterdam, 183-192, 1986
6. Ventafridda V, Oliveri E., Caraceni A et al.: A retrospective study on the use of oral morphine in
cancer pain. J Pain Sympt Manag 2: 77-81, 1987. (IF 0)
7. M. TAMBURINI, S. SELMI, F. DE CONNO, V. VENTAFRIDDA: Semantic descriptors of pain.
Pain, 187-193, 1987
8. V. VENTAFRIDDA, C. RIPAMONTI, F. DE CONNO, M. BIANCHI, F. PAZZUCCONI, A. PANERAI:
Antidepressants increase bioavailability of morphine in cancer patients. The Lancet, May 23, 1987
9. V. VENTAFRIDDA, S. SELMI, G. DI MOLA, M. TAMBURINI, F. DE CONNO: A new model of
continuing care for advanced cancer pain treatment. The Hospice Journal, 85-99, 1987
10. Ventafridda V, Tamburini M, Caraceni A et al.: A validation study of the WHO method for cancer
pain relief. Cancer 59: 850-857, 1987. (IF 2,343)
11. Ventafridda V, Spoldi E, Caraceni A, De Conno F: Intraspinal morphine for cancer pain. Acta
Anaestesiol Scand 31, S85: 47-53, 1987. (IF 0,974)
12. Caraceni A: Availability and use of opioids for cancer pain patients in Italy. J Pain Sympt Manag
2: 127-128, 1987 * (IF 0)
13. Ventafridda V, Bonezzi C, Caraceni A et al.: Antidepressants for cancer pain and other painful
syndromes with deafferentation component: comparison of amytriptiline and trazodone. It J
Neurol Sci 8: 579-587, 1987. (IF 0,189)
14. F. DE CONNO, L. SAITA, V. VENTAFRIDDA: La thermocoagulation controlee au niveau de L5S1 dans les algies perineales dues a un cancer avance. Douleur e Analgesie, 1, 79-82, 1988
15. V. VENTAFRIDDA, E. SPOLDI, F. DE CONNO, A. CARACENI: Trattamento farmacologico del
dolore cronico da cancro: gli oppioidi. Argomenti di Oncologia, 9, 213-221, 1988
16. U. VERONESI, F. DE CONNO, M. GALLUCCI, V. VENTAFRIDDA: Dolore e terapia del dolore.
Enciclopedia del novecento. Vol. VIII, 754-763, 1989
17. V. VENTAFRIDDA, L. SAITA, L. BARLETTA, F. DE CONNO: Clinical observations on controlled
1
release morphine in cancer pain. Journal of pain and symptom management. Vol. 4, 124-129,
1989
18. V. VENTAFRIDDA, E. SPOLDI, F. DE CONNO: The control of dyspnea in advanced cancer
patients. Chest, Vol.98, 6, 1544, 1990
19. V. VENTAFRIDDA, F. DE CONNO, C. RIPAMONTI, A. GAMBA, M. TAMBURINI: Quality of life
assesment during a palliative care programme. Annals of oncology. 1: 415-420, 1990
20. V. VENTAFRIDDA, M. BIANCHI, C. RIPAMONTI, P. SACERDOTE, F. DE CONNO, E. ZECCA, A.
PANERAI: Studies on the effects of antidepressant drugs on the antinociceptive action of
morphine and on plasma morphine in rat and man. Pain. 43, 155-162, 1990
21. V. VENTAFRIDDA, A. SBANOTTO, F. DE CONNO: Pain in prostatic cancer. Palliative Medicine.
4, 173-184, 1990
22. V. VENTAFRIDDA, F. TOSCANI, M. TAMBURINI, O. CORLI, M. GALLUCCI, A. GOTTLIEB, R.
SPERANZA, F. DE CONNO: Sodium naproxen vs. diclofenac in cancer pain control. Arzneim.
Forsch. Drug Res. 40, 1132-1134, 1990
23. Ventafridda GV, Caraceni AT, Sbanotto A, Barletta L, De Conno F: pain treatment in cancer of the
pancreas. Eur J Surg Oncol 16: 1 -6, 1990. * (IF 0)
24. Ventafridda V, Ripamonti C, Caraceni A, Spoldi E, Messina L, De Conno F. The management of
gastrointestinal obstruction in terminal cancer patients. Tumori 76: 389-393, 1990. * (IF 0,571)
25. Ventafridda V, Caraceni A, Martini C, Sbanotto A, De Conno F. On the significance of Lhermitte's
sign in Oncology. J Neurooncol 10: 133-137, 1991. (IF 1,063)
26. Ventafridda V, Caraceni A. Cancer pain classification a controversial issue. Pain 46: 1-2, 1991. (IF
3,492)
27. De Conno F, Caraceni A, Martini C, Spoldi E, Salvetti M, Ventafridda V. Hyperalgesia and
myoclonus with high-dose intrathecal morphine. Pain 47: 337-339, 1991. (IF 3,492)
28. De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafridda V. The continuous SC infusion of
hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain
Sympt Manag 6: 484-486, 1991. (IF 0)
29. De Conno F, Spoldi E, Caraceni A, Ventafridda V. Does pharmacological treatment affect the
sensation of breathlessness in terminal cancer patients ? Palliative Medicine 5: 237-243 1991.
(IF 0)
30. F. DE CONNO, L. SAITA, V. VENTAFRIDDA: Skin problems in advanced and terminal cancer
patients. Journal of Pain and Symptoms Management. 6, 247-256, 1991
31. V. VENTAFRIDDA, F. DE CONNO, L. SAITA, C. RIPAMONTI, G.F. BARONZIO: Leucocytelymphocyte ratio as prognostic indicator of survival in cachectic cancer patients. Annals of
oncology. 2: 196, 1991
32. F. DE CONNO, C. RIPAMONTI, A. SBANOTTO, L. BARLETTA, E. ZECCA, C. MARTINI, V.
VENTAFRIDDA: A clinical study on the use of codeine, oxycodone, dextropropoxyphene,
buprenorphine and pentazocine. J. of pain and symptom management.7, 423-427, 1991
33. M. TAMBURINI, S. ROSSO, A. GAMBA, E. MENCAGLIA, F. DE CONNO, V. VENTAFRIDDA: A
therapy impact questionnaire for quality of life assessment in advanced cancer research. Annals
of oncology, 3: 565-570, 1992
34. Caraceni A. Martini C., Belli F., Mascheroni L., Rivoltini L., Arienti F., Cascinelli N.
2
Neuropsychological and neurophysiological assessment of Interleukin-2 administration. Eur J
Cancer, 29A: 1266-1269 1993 (IF 2,191)
35. Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti M T. Octreotide in relieving
gastrointestinal symptoms due to bowel obstruction. Palliative Medicine, 7: 255-299, 1993 (IF 0)
36. F. DE CONNO, C. RIPAMONTI, A. SBANOTTO, L. SAITA, E. ZECCA, V. VENTAFRIDDA: The
pharmacological management of cancer pain: the role of non opioid and adjuvant drugs. Annals of
oncology, 4: 187-193, 1993
37. V. VENTAFRIDDA, F. DE CONNO, H. BLUMHUBER: The situation of palliative care in Europe.
Journal of Pain and Symptom Management, Vol. 8, 6, 369-371, 1993
38. De Conno F., Caraceni A., Aldrighetti et al. Paraplegia following celiac plexus block. Pain 55:
383-385, 1994. (IF 3,408)
39. De Conno F, Caraceni A, Gamba A, et al . Pain measurement in cancer pain a comparison of six
methods. Pain 57: 161-166, 1994. (IF 3,408)
40. De Conno F, Zecca E, Martini C, Ripamonti C., Caraceni A, Saita L. Tolerability of ketorolac
administered via continuous subcutaneous infusion for cancer pain. J Pain Sympt Manage, 9:
119-121, 1994. (IF 0,908)
41. Caraceni A, Martini C, De Conno F, Ventafridda V Organic brain syndromes and opioid
administration for cancer pain J Pain Symp Manage 9: 527-533, 1994. * (IF 0,908)
42. Capri G, Munzone E, Tarenzi E, Fulfaro F, Gianni L, Caraceni A, Martini C, Scaioli V. Optic
nerve disturbances a new form of paclitaxel neurotoxicity. J Nat Cancer Institute , 86:1099-1101,
1994. (IF 7,454)
43. Bortolussi R, Fabiani F, Savron F, Testa V, Lazzarini R, Sorio R, De Conno F, Caraceni A Acute
morphine intoxication during high-dose recombinant iterleukin-2 treatment for metastatic renal cel
cancer. Eur J Cancer 30A: 1905-1907, 1994. (IF 1,959)
44. Gianni L, Munzone E, Capri G, Villani F, Spreafico E, Tarenzi E, Fulfaro F, Caraceni A , Martini
C, Laffranchi A, Valagussa P, Bonadonna G. Paclitaxel in metastatic breast cancer: a trial of two
doses by 3-hour infusion in patients with disease recurrence after prior therapy with
anthracyclines. J Nat Cancer Institute 87: 1169-1175, 1995. (IF 9,455)
45. Scaioli V., Caraceni A, Martini C, Palazzini E, Tarenzi E, Fulfaro F, Munzone E. Visual evoked
potential findings in course of paclitaxel chemotherapy for breast cancer. Journal of Neurooncology, 25: 221-225, 1995. (IF 1,096)
46. Gianni L, Munzone E, Capri G, Fulfaro F, Tarenzi E, Villani F, Spreafico C, Laffranchi A, Caraceni
A, Martini C, Stefanelli M, Valagussa P, Bonadonna G. Paclitaxel 3-hour infusion in combination
with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy
and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 13: 2688-2699,
1995. (IF 7,507)
47. Maltoni M, Pirovano M, Scarpi E, et al Prediction of survival patients terminally ill with cancer.
Results of an Italian prospectivemulticentricstudy. Cancer 75: 2613-2623, 1995 vedi lista dei
coautori (IF 0,773)
48. 175)
F. DE CONNO, C. RIPAMONTI, L. SAITA, T. MACEACHERN, J. HANSON, E. BRUERA:
3
Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus
rectal morphine administration in opioid-naive cancer patients with pain. J. of Clin. Onc. Vol. 13,
N. 4, 1004-1008, 1995
49. Caraceni A.
Clinicopathological correlates of common cancer pain syndromes
Hematology/Oncology Clinics of North America, 10: 57-78, 1996. (IF 1,960)
50. Terenziani, M, De Micheli , Brambilla , Ferrari, Moliterni, Zambetti M, Caraceni A, Martini C,
Vinorelbine: a active non cross-resistant drug in advanced breast cancer a phase II Study. Breast
Cancer Research and Treatment 39: 285-291, 1996. * (IF 2,879)
51. Caraceni A, Portenoy R K. Pain management in Pancreatic cancer. Cancer 78: 639-653, 1996.
(IF 2,864)
52. Caraceni A, Mendoza T, Mencaglia E, Baratella C., Edwards K, Forjaz MJ, Martini C, Serlin R,
De Conno F, Cleeland C. A Validation Study of an Italian Version of the Brief Pain Inventory
(Breve Questionario Per La Valutazione Del Dolore). Pain 65: 87-92, 1996. (IF 3,836)
53. De Conno F, Caraceni A, Groff L, Brunelli C, Tamburini M, Donati I, Ventafridda VEffect of homecare on the place of death of advanced cancer patients Eur J Cancer 32A: 1142-1147, 1996.
(IF 2,095)
54. M. TAMBURINI, C. BRUNELLI, S. ROSSO, V. VENTAFRIDDA, contriburors F. DE CONNO et.
al.: Prognostic value of quality of life scores in terminal cancer patients. J. of Pain and S. Man.
Vol. 11, 1, 32-41, 1996
55. G. HANKS, F. DE CONNO , M. HANNA, H.J. Mc QUAY, S. MERCADANTE, J. MEYNADIER, P.
POULAIN, C. RIPAMONTI, J. SAWE, R. TWYCROSS, A. VAINIO, D. ZECH: Morphine in cancer
pain: Modes of administration. B.M.J. 312: 823-6, 1996.
56. F. BOZZETTI, D. AMADORI, E. BRUERA, L. COZZAGLIO, O. CORLI, A. FILIBERTI, C.H.
RAPIN, H. NEUENSCHWANDER, M. AOUN, S. BASSO RICCI, F. DE CONNO, R. DOCI, M.
GARRONE, M. GENTILINI, N. LERY, M. MANTELL, R. SHELDON COLLINS, G. TROMPINO:
Consensus meeting on artificial nutrition versus hydration in terminal cancer patients. Nutrition,
vol12, 3, 169-172, 1996
57. C. RIPAMONTI, E. ZECCA, C. BRUNELLI, E. RIZZIO, L. SAITA, F. LODI, F. DE CONNO: Rectal
methadone in cancer patients with pain. Annals of oncology, 6, 841-843, 1995
58. V. VENTAFRIDDA, F. DE CONNO: Report on the activities of the Milan World Health
Organization Collaborating Center. J.P.S.M. 2, 79-81, 1996
59. H. BLUMHUBER, F. DE CONNO, G.W. HANKS: Report of the European Association for Palliative
Care. J.P.S.M. 2, 82-84, 1996
60. Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, Gramazio R., Terzoli E, Luzzani M, De
Marinis F, Caraceni A., Labianca R. Biological indices predictive of survival in 519 Italian
terminally-ill cancer patients. J Pain Symtpom Manage 13: 1-9, 1997. (IF 2,091)
61. Caraceni A., Martini C, Spatti G, Thomas A, Onofrj Recovering optic neuritis during systemic
cisplatin and carboplatin chemotherapy Acta Neurologica Scandinavica 96: 260-261, 1997. (IF
1,068)
62. Caraceni A., Martini C, Zecca E, De Conno F, Portenoy RK. Pain due to epidural tumor in cancer
patients report of two cases and differential diagnosis Italian Journal of Neurological Sciences 18:
303-307, 1997. (IF 0,261)
63. Formaglio F, Caraceni A Meningeal metastastes: clinical aspects and diagnosis. Ital J Neurol Sci
4
19: 133-149, 1998. (IF 0,418)
64. Caraceni A, Gangeri L, Martini C, Belli F, Brunelli C, Baldini M, Mascheroni L, Lenisa L, Cascinelli
N. Neurotoxicity of interferon-alpha in melanoma therapy. Results from a randomized controlled
trial. Cancer 83: 482-489, 1998. (IF 3,296)
65. Caraceni A., Beltrami E, Borreani C, Grassi L. La diagnosi e la valutazione dello stato
confusionale acuto (delirium). Quaderni di Cure Palliative 6: 10-18, 1998 (IF 0)
66. De Conno F, Martini C, Zecca E, Balzarini A, Venturino P, Groff L, Caraceni A. Megestrole
acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial
Eur J Cancer 34: 1705-179, 1998. (IF 2,407)
67. C. RIPAMONTI, E. ZECCA, C. BRUNELLI, F. FULFARO, S. VILLA, A. BALZARINI, E.
BOMBARDIERI, F. DE CONNO: A randomized controlled clinical trial to evaluate the role of zinc
sulphate administration in cancer patients with taste alterations due to head and neck irradiation.
Cancer, 1938-1945, 1998
68. C. RIPAMONTI, F. DE CONNO, L. GROFF, M. BELZILE, J. PEREIRA, J. HANSON, E. BRUERA:
Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain:
Comparison of two clinical experiences. Annals of Oncology, 9: 79-83, 1998
69. C. RIPAMONTI, L. GROFF, C. BRUNELLI, D. POLASTRI, A. STAVRAKIS, F. DE CONNO:
Switching from morphine to oral methadonein treating cancer pain: what is the equianalgesic dose
ratio? J.C.O. vol.16, 10, 3216-3221, 1998
70. F. DE CONNO, R. BOFFI, L. SAITA: Eighteen years of home care: from assistance by phone to a
complete service within the health care system. Journal of Palliative Care, 14, 3, 91-93, 1998
71. A. BALZARINI, F. GARIBOLDI, F. DE CONNO: La riabilitazione. In: La patologia mammaria
dell'età senile ed. E.L.Galante. Il pensiero scientifico, 157-166, 1998
72. M. MERSON, A. BALZARINI, F. BOSELLO, F. VALESELLA, B. COTZA, M.G. BLANDINI, W.
BORDET, P. CAMPANINI, L. CAVALLINI? R. CESTAROLLI, G. CHIMENTO, C. FICCARELLI, D.
FICCHI, P. PLACUCCI, F. DE CONNO: Archery as a possible rehabilitative activity in the
oncological structure: preliminary observations from a feasibility study. Tumori, 614-615, 84, 5,
1998
73. Portenoy, R.K., Caraceni A., Cherny N I, Goldblum R, Ingham J, Inturrisi C.E., Johnson J.H.,
Lapin J., Tiseo P.J., Kreek M.J. Dynorphin A(1-13) analgesia in opioid treated patients with
chronic pain. A controlled pilot study. Clin Drug Invest 17: 33-42, 1999. (IF 0,710)
74. Bohm S, Oriana S, Spatti G, Di Re F, Bresciani G, Pirovano C, Grosso I, Martini C, Caraceni A,
Pilotti S, Zunino F. Dose intensification of platinum compounds with glutathione protection as
induction chemotherpy for advanced ovarian carcinoma. Oncology 57: 115-120, 1999 (IF 2,858)
75. Caraceni A, Portenoy RK, a Working group of the IASP Task Force on Cancer Pain. An
International survey of cancer pain characteristics and syndromes. Pain 82: 263-274, 1999. (IF
3,802)
76. Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as adjuvant to opioid analgesia for
neuropathic cancer pain J Pain Sympt Manage 17 (6) : 441-445, 1999. (IF 1,508)
77. Maltoni M. Nanni O, Pirovano M et al Successful validation of the Palliative prognostic score in
terminally ill cancer patients. J Pain Symptom Manage 17: 240-247, 1999 vedi lista dei coautori
(IF 1,508)
5
78. Pirovano M, Maltoni M, Nanni O et al A new palliative prognostic score: a first step for the staging
of terminally ill cancer patients. J Pain Symptom Manage 17: 231-239, 1999 vedi lista dei
coautori (IF 1,508)
79. Caraceni A, Scolari S, Gallino G, Simonetti F. Meningeal metastases from malignant melanoma
presenting with gaze-evoked tinnitus. Neurology 1999; 53: 2207-2208 * (IF 4,972)
80. L. SAITA, D. POLASTRI, F. DE CONNO: Visual disturbances in advanced cancer patients: clinical
observations. J.P.S.M. 17, 3, 224-226, 1999
81. BALZARINI, E. FELISI, A. MARTINI, F. DE CONNO: Efficacy of homeopathic tretment of skin
reaction,s during radiotherapy for breast cancer: a randomised, double-blind clinical trial; British
Homeopathic Journal, 88, 1-5, 1999
82. PERUSELLI, P. DI GIULIO, F. TOSCANI…………….F. DE CONNO, L. GROFF et al.: Home
palliative care for terminal cancer patients: a survey on the final week of life. Palliative Medicine,
13, 233-241, 1999
83. M. COSTANTINI, F. TOSCANI, M. GALLUCCI…………….F. DE CONNO, L. GROFF et al.:
Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort
study. J.P.S.M., vol. 18, 4, 243-252, 1999
84. T. TORELLI, M. COLAVITA, A. MILANI, G. PIZZOCCARO, S. NERVI, B. COTZA, R.
CESTAROLLI, C. FICCARELLI, F. DE CONNO: Early rehabilitation of the perineal plane for the
treatment of incontinence after radical prostatectomy. International Journal of the Proctological
and Perineal Diseases, III, 93-96, 1999
85. Caraceni, A., O. Nanni, Maltoni M, Piva L, Indelli M, Arnoldi E, Monti M, Montanari, L, Amadori D,
De Conno, Italian Multicenter Study Group on Palliative Care The impact of delirium on the shortterm prognosis of advanced cancer patients. Cancer 89: 1145-1149, 2000. (IF 3,632)
86. Defanti C.A and the ad hoc working group of the Italian neurological society. Study group of
bioethics and palliative care in neurology: program document Neurol Sci 2000; 21: 261-265 (IF 0)
87. Ripamonti C, Zecca E, Brunelli C, Groff L, Boffi R, Caraceni A, Galeazzi G, Martini C, Panzeri C,
Saita L, Viggiano V, De Conno F. Pain experienced by patients hospitalized at the National
Cancer Institute of Milan: research project "towards a pain-free hospital".Tumori. 2000 SepOct;86(5):412-8. (IF 0,569)
88. A. BALZARINI, C. SIGARI, F. DE CONNO: La terapia riabilitativa dell’edema dell’arto superiore.
Linfologia, 4, 16-19, 2000
89. C. RIPAMONTI, S. MERCADANTE, L. GROFF, E. ZECCA, F. DE CONNO, A. CASUCCIO: Role
of octrotide, scopolamine butylbromide, and hydration in symptom control of patients with
inoperable bowel obstruction and nasogastric tubes: a prospective randomised trial. J.P.S.M., 19,
23-34, 2000
90. A. BALZARINI, E. FELISI, A. MARTINI, F. DE CONNO: Efficacy of homeopathic treatment of skin
reactions during radiotherapy for breast cancer: a randomised, double blind clinical trial. British
Homeopathic Journal, 89, 8-12, 2000
91. BALZARINI A., PLACUCCI P., CRABA L., CAMPANINI P., DE CONNO F. Trattamento
riabilitativo dei pazienti con tumore del distretto cervico-facciale. Attualità in Terapia Manuale &
Riabilitazione, 3, 27-33, 2000
92. Grassi L, Caraceni A, Beltrami E, Zamorani M, Maltoni M, Monti M, Luzzani, M, Mercadante S, De
Conno F. Assessing delirium in cancer patients the Italian versions of the Delirium Rating Scale
and the Memorial Delirium Assessment Scale. J Pain Symptom Manage 2001; 21: 59-68. (IF
6
1,837)
93. Caraceni A, Gorni G., Zecca E, De Conno F. More on the use of nonsteroidal anti-inflammatories
in the management of cancer pain. J Pain Sympt Manage 2001; 21: 89-92 (IF 1,837)
94. Caraceni, A., Evaluation and assessment of cancer pain and cancer pain treatment, Acta
Anaesthesiol Scand, 45 (2001) 1067-1075 (IF 1,073)
95. Hanks, G. de Conno F, Cherny N, Hanna, M. Kalso E, McQuay HJ, Mercadante S, Poulain P,
Ripamonti C, Radbruch L, Roca I Casas J, Twycross RG, Ventafridda V and the steering
committee of the research Network of the EAPC* (De Conno Chair. A Caraceni, N Cherny, J
Ferraz Goncalves, CJ Furst, GW Hanks, S Kaasa, S Mercadante, JN Nunez Olarte, P Poulain, L
Radbruch, C Ripamonti, F Stiefel) Morphine and alternative opioids in cancer patients the EAPC
recommendations Br J Cancer 2001; 84: 587-593 (IF 3,489)
96. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay HJ, Mercadante S, Pasternak G,
Ventafridda for the expert working group of the European Association of Palliative Care (De
Conno Chair. A Caraceni, N Cherny, J Ferraz Goncalves, CJ Furst, GW Hanks, S Kaasa, S
Mercadante, JN Nunez Olarte, P Poulain, L Radbruch, C Ripamonti, F Stiefel, P. Thomas).
Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin
Oncol 2001; 19: 2542-2554 * (IF 8,773)
97. RIPAMONTI C, TWYCROSS R., BAYNES M., BOZZETTI F., CAPRI S., DE CONNO F., GEMLO
B., HUNT T., KREBS H., MERCADANTE S., SHAERER R., WILKINSON P.(Working group of the
European Association for Palliative Care): Clinical practice recommendations on the management
of bowel obstruction in patients with end-stage cancer. Supportive Care in Cancer, 9, 223-233,
2001
98. FILIBERTI A, RIPAMONTI C, TOTIS A, VENTAFRIDDA V, DE CONNO F, CONTIERO P,
TAMBURINI M. Characteristics of terminal cancer patients who committed suicide during a home
palliative care programme. J Pain Symptom Manage, 22, 544-553, 2001
99. HANKS GW., DE CONNO F., CHERNY N., HANNA M., KALSO E., MC QUAY HJ.,
MERCADANTE S., MEYNADIER J., POULAIN P., RIPAMONTI C., RADBRUCH L., ROCA I
CASAS J., SAWE J., TWYCROSS RG., VENTAFRIDDA V. and steering committee of the RN of
the EAPC (De Conno chair, Caraceni, Cherny, Furst, Ferraz Gonsalves, Hanks, Nunez Olarte,
Poulain, Radbruch, Ripamonti, Stiefel): Morphine and alternative opioids in cancer pain: the
EAPC recommendations. BJC, 84, 587-593, 2001
100.
CHERNY N., RIPAMONTI C., PEREIRA J., DAVIS C., FALLON M., MC QUAY H.,
MERCADANTE S., PASTERNAK G., VENTAFRIDDA V. and steering committee of the RN of the
EAPC (De Conno chair, Caraceni, Cherny, Furst, Ferraz Gonsalves, Hanks, Nunez Olarte,
Poulain, Radbruch, Ripamonti, Stiefel): Strategies to manage the adverse effects of oral
morphine: an evidence based report. J.C.O., 9, 2542-2554, 2001
101.
STIEFEL F., DIE TRILL M., BERNEY A., NUNEZ OLARTE JM., RAZAVI D. and the
steering committee of the RN of the EAPC (De Conno chair, Caraceni, Cherny, Furst, Ferraz
Gonsalves, Hanks, Nunez Olarte, Poulain, Radbruch, Ripamonti, Stiefel): Depression in paliative
care: a pragmatic report from the expert working group of the EAPC. Support Care Cancer, 9,
477-488, 2001
102.
BALZARINI A., CRABA L., PLACUCCI P., FAINI A., VIECELI C., DE CONNO F.:
Valutazione statica e dinamica degli esiti da dissezione laterocervicale. Attualità in Terapia
Manuale e Riabilitazione, Vlo. 3, 1, 31-34, 2001
103.
BALZARINI A., MILELLA M., CIVELLI E., SIGARI C., DE CONNO F.: Ultrasonography of
arm edema after axillary dissection for breast cancer: a preliminary report. Lymphology, in press
7
104.
Caraceni, A., Cherny, N., Fainsinger, R., Kaasa, S., Poulain, P., Radbruck, L., De Conno,
F. and And-the-steering-committee-of-the-EAPC research-network, Pain measurement tools and
methods in clinical research in palliative care: recommendations of an expert working group of the
European Association of Palliative Care, J Pain Sympt Manage, 23 (2002) 239-255. (IF 2,119)
105.
Mercadante, S., Radbruch, L., Caraceni, A., Cherny, N., Kaasa, S., Nauck, F., Ripamonti,
C., De Conno, F. and and-the-members-of-the-steering-committee-of-the-EAPC-researchnetwork, Episodic (breakthrough) pain. Consensus conference of an expert working group of the
European Association for Palliative Care, Cancer, 94 (2002) 832-839. (IF 3,909)
106.
Caraceni A, Galbiati A , Brunelli C, Gorni G, Martini C, Zecca E, De Conno F. Cancer
patients compliance in the self administration of a pain assessment tool J Pain Sympt Manage
2004; 27: 417-424 (IF 1,885)
107.
Caraceni A, Martini C, Zecca,E, Portenoy RK, and a Working Group of an IASP Task
Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer
pain. An international survey. Pall Med 2004; 18: 177-183. (IF 1,185)
108.
Caraceni A., Zecca E, Bonezzi C, Arcuri E, Yaya Tur R, Maltoni M,Visentin M, Gorni G,
Martini C, Tirelli W, Barbieri M, De Conno F. Gabapentin for neuropathic cancer pain: a
randomized controlled trial from the gabapentin cancer pain study group J Clin Oncol 2004; 22:
2909-2917 (IF 10,864)
109.
Caraceni A, Simonetti F Psychostimulants: new concepts for palliative care from the
modafinil experience ? J Pain Sympt Manage 2004; 28: 97-99 (IF 1,885)
110.
Caraceni A, Andreola S , Simonetti F, Celio L. Acute confusional state with fatal outcome
in a cancer patient. Neurol Sci 2003; 24 424-425(IF 0,907)
111.
Bianchi G.L., Vitali G., Caraceni A., Ravaglia S., Capri G., Cundari S., Zanna C., Gianni
L.: Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy
to oral acetyl-l-carnitine. Eur J Cancer 2005; 41: 1746-1750 (IF 3,302)
112.
Caraceni A., Brunelli C., Martini C., Zecca E., De Conno F.: Cancer pain assessment in
clinical trials. A review of the literature (1999-2002). J Pain Symptom Manage 2005; 29: 507-519
(IF 2,187)
113.
Klepstad P., Kaasa S., Cherny N., Hanks G., De Conno F and the research steering
committee of the EAPC.: Pain and pain treatments in European palliative care units. A cross
sectional survey from the European Association for Palliative Care Research Network. Pall Med
2005; 19: 477-484 [IF 1,268]
114.
Maltoni M., Caraceni A., Brunelli C., Broeckaert B., Christakis N., Eychmueller S.,Glare
P., Nabal M., Viganò C., Larkin P., De Conno F., Hanks G., Kaasa S.: Prognostic factors in
advanced cancer patients: evidence-based clinical recommendations--a study by the Steering
Committee of the European Association for Palliative Care. J Clin Oncol 2005; 23: 6240-6248 (IF
9,835)
115.
Spinazzé S., Caraceni A., Schrijvers D.: Epidural spinal cord compression. Crit Rev
Oncol Hematol 2005; 56: 397-406 (IF 2,667)
116. Scaioli V, Caraceni A, Martini C, Curzi S, Capri G, Luca G.Electrophysiological evaluation of
visual pathways in paclitaxel-treated patients. J Neurooncol. 2006; 77 :79-87 (IF 2,325)
8
117. Bonito V, Caraceni A, Borghi L, Marcello N, Mori M, Porteri C, Casella G, Causarano R,
Gasparini M, Colombi L, Defanti CA; SIN Bioethics and Palliative Care Study Group The clinical
and ethical appropriateness of sedation in palliative neurological treatments. Neurol Sci. 2005;
26(5):370-85. (IF 0,779)
118. Bosisio M, Caraceni A, Grassi L Italian Delirium Study Group.Phenomenology of delirium in
cancer patients, as described by the Memorial Delirium Assessment Scale (MDAS) and the
Delirium Rating Scale (DRS). Psychosomatics. 2006 Dec;47(6):471-478. (IF 2,336)
119. Cicero G, Fulfaro F, Caraceni A, Arcara C, Badalamenti G, Intrivici C, Gebbia N. A case of
Guillain-Barre syndrome in a patient with non small cell lung cancer treated with chemotherapy. J
Chemother. 2006 Jul;18(3):325-7. (IF 1,147)
120. Holen JC, Hjermstad MJ, Loge JH, Fayers PM, Caraceni A, De Conno F, Forbes K, Furst CJ,
Radbruch L, Kaasa S. Pain assessment tools: is the content appropriate for use in palliative care
? J Pain Symptom Manage. 2006 Dec;32(6):567-80. (IF 2,309)
121. Kaasa S, Torvik K, Cherny N, Hanks G, De Conno Patient demographic and centre description
in European palliative care units. A cross-sectional survey of the European Association for
Palliative Care (EAPC) Research Network. Pall Med 2007; 21: 15-22 collective authorship (IF
1,939)
122. Gangeri L., Bosisio M., Brunelli C. Tamburini M., Serafin P., Clerici C. A., Caraceni A.,
Mazzaferro V., “Phenomenology and emotional impact of neuropsychiatric symptoms in orthotopic
liver transplant for hepatocellular carcinoma”, Transplantation Proceedings 2007 39: 1564-1568,
(IF: 0,762)*
123. Cavaletti G, Frigeni B, Lanzani F, Piatti M, Rota S, Briani C, Zara G, Plasmati R, Pastorelli F,
Caraceni A, Pace A, Manicone M, Lissoni A, Colombo N, Bianchi G, group ftIN: The total
neuropathy score as and assessment tool for grading the course of chemotherapy-induced
peripheral neurotoxicity : comparison with the National Cancer Institute- Common Toxicity Scale.
J Periph Nervous Syst 2007; 12: 210-215 (IF 2,065)
124. Caraceni A, Zecca E, Martini C, Pigni A, Bracchi P Gabapentin for breakthrough pain due to
bone metastases Pall Med 2008; 22: 392-393 (IF 1,652)
125. Tassinari D, Montanari L, Maltoni M, Ballardini M, Piancastelli, A Musi M, Porzio G, Minotti V,
Caraceni A, Poggi B, Stella A, Aielli F, Scarpi E. The palliative prognostic score and survival in
patients with advanced solid tumors receivig chemotherapy Supp Care Cancer 2008; 16: 359-370
(IF 2,122)
126. Kaasa S., Loge JH, Fayers P, Caraceni A, Strasser F, Hjermstadt M, Higginson I, Radbruch L,
Haugen DK on behalf of EPCRC Symptom assessment in palliative care: a need for international
collaboration J Clin Oncol 2008; 23: 3867-3873 (IF 15,484)
127. Hjemstad M, Gibbins J, Haugen DF, Caraceni A , Loge JH, Kaasa S, on behalf of the EPCRC
European Palliative Care Research Collaborative Pain Assessment tools in palliativ care an
urgent need for consensus Pall Med 2008 22: 1-9 (IF 1,652)
128. Bonito B, Primavera A, Borghi L, Mori M, De Fanti CA on behalf of the 23: 131-139e Working
Group on Bioethics and Palliative Care in Neurology Neurol Sci 2002; (?)
129. Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, La Bianca R, Maltoni M, Nicora M,
Torri V, Zucco F and the Cancer Pain Outcome Research Study Group, Pain in cancer. An out
9
come research project to evaluate the epidemiology, the quality and the effects of pain treatment
in cancer patients. Health and Qualiy of Life Outcomes 2006 4: 7 doi: 10.1186/1477-7525-4-7
(IF 0)
130.
Greco MT, Deandrea S, Corli O, Montanari M, Caraceni A, Apolone G a nome degli
investigatori del Cancer Pain Outocome Research Study Group (CPOR SG) Effetti della
somministrazione di buprenorfina transdermica in pazienti oncologici. Risultati di uno studio di
outcome Recenti Progressi in Medicina 2008; 99: 538-552 (IF 0)
131.
Caraceni A, Miccoli P, Martini C , Curzi S, Cresta S, Gianni L, Scaioli V. Peripheral
neuropathy due to paclitaxel : study of the temporal relationship between the therapeutic schedule
and the clinical quantitative score (QST) and comparison with neurophysiological findings. J
Neuroncol 2008; 86 : 89-99 (IF 1,856)
132.
Caraceni A, Simonetti F Palliating delirium in cancer patients Lancet Oncology 2009; 10:
164-172 (IF 13,283)
133.
Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT; Cancer Pain Outcome
Research Study Group (CPOR SG) Investigators, Apolone G, Bertetto O, Caraceni A, Corli O, De
Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F. Effects of transdermal
buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain
Outcome Research (CPOR) Study Group. Clin J Pain. 2009 Oct;25(8):671-82. (IF 2,889)
134.
Apolone G, Corli O. ,Caraceni A, Negri E., Deandrea S, Montanari M, Greco MT, on
behalf of the Cancer Pain Outcome Research Study Group (CPOR SG) Investigators* Pattern
and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research
Study Group (CPOR SG). Br J Cancer 2009; 100: 1566-1574 (IF 4,846)
135. Knudsen AK, Aass N, Fainsinger R, Caraceni A, Klepstad P, Jordhøy M, Hjermstad MJ, Kaasa
S 1: Classification of pain in cancer patients--a systematic literature review. Palliat Med. 2009
Jun;23(4):295 308. Epub 2009 Mar 13. (IF 1,874)
136. Wasteson E, Brenne E, Higginson IJ, Hotopf M, Lloyd-Williams M, Kaasa S, Loge JH;
European Palliative Care Research Collaborative (EPCRC). Depression assessment an d
classification in palliative cancer patients: a systematic literature review Palliat Med. 2009
Dec;23(8):739-53. Epub 2009 Oct 13. Collaborators: Kaasa S, Skorpen F, Hjermstad MJ, Loge
JH, Hanks G, Caraceni A, De Conno F, Higginson I, Strasser F, Radbruch L, Fearon K, Samonigg
H, Bø K, Schaude M, Gundersen OE, Aaronson N, Baracos V, Fainsinger R, Stone PC, Williams
ML, Kaasa S, Dale O, Haugen DF. (IF 1,874)
137.
Beccaro M., Caraceni A., Costantini M., on behalf of the ISDOC Study Group: End-of- life
care in Italian hospitals: quality of and satisfaction with care from the caregivers' point of view-results from the Italian Survey of the Dying of Cancer. J Pain Symptom Manage 2010; 39: 10031015 (IF 2,423)
138.
Brunelli C., Zecca E., Martini C., Campa T., Fagnoni E., Bagnasco M., Lanata L.,
Caraceni A.: Comparison of numerical and verbal rating scales to measure pain exacerbations in
patients with chronic cancer pain. Health Qual Life Outcomes 2010; 8: 42 (IF 2,456)
139.
Caraceni A., Cavaliere F., Galante D., Landoni G.: A year in Review in Minerva
Anestesiologica, 2009. Minerva Anestesiol 2010; 76: 158-168 (IF 1,614)
10
140.
Caraceni A., Zecca E., Martini C., Brunelli C., Pigni A., Gorni G., Galbiati A., Ibazeta M.,
Hjermstad M., Kaasa S.: The validity of average 8-h pain intensity assessment in cancer patients.
Eur J Pain 2010; 14: 441-445 (IF 3,612)
141.
Haugen D., Hjermstad M.J., Hagen N., Caraceni A., Kaasa S., European Palliative Care:
Research Collaborative (EPCRC). Assessment and classification of cancer breakthrough pain: a
systematic literature review. Pain 2010; 149: 476-482 (IF 5,371)
142.
Pigni A., Brunelli C., Gibbins J., Hanks G., Deconno F., Kaasa S., Klepstad P., Radbruch
L., Caraceni A.: Content development for European guidelines on the use of opioids for cancer
pain: a systematic review and Expert Consensus Study. Minerva Anestesiol 2010; 76: 833-843
(IF 1,614)
143.
Galvan A, Skorpen F, Klepstad P, Knudsen AK, Fladvad T, Falvella FS, Pigni A, Brunelli
C, Caraceni A, Kaasa S, Dragani TA. Multiple loci modulate opioid therapy response for cancer
pain. Clin Cancer Res. 2011 17 (13) : 4581-7 May 27. [Epub ahead of print] PubMed PMID:
21622719. (IF 7,338)
144.
Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R,
Aass N, Kaasa S; European Palliative Care Research Collaborative (EPCRC). Studies comparing
numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain
intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011 Jun;41(6):107393. PubMed PMID: 21621130. (IF 2,640)
145.
Fayers PM, Hjermstad MJ, Klepstad P, Loge JH, Caraceni A, Hanks GW, Borchgrevink P,
Kaasa S; On behalf of the European Palliative Care Research Collaborative (EPCRC). The
dimensionality of pain: Palliative care and chronic pain patients differ in their reports of pain
intensity and pain interference. Pain. 2011 152: 1608 - 1620: 21458921. (IF 5,355)
146.
Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M,
Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM,
Kaasa S; On behalf of the European Palliative Care Research Collaborative (EPCRC) and the
European Association for Palliative Care Research Network. Influence from genetic variability on
opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients.
Pain. 2011 May;152(5):1139-1145. (IF 5,355)
147.
Raijmakers NJ, van Zuylen L, Costantini M, Caraceni A, Clark J, Lundquist G, Voltz R,
Ellershaw JE, van der Heide A; on behalf of OPCARE9. Artificial nutrition and hydration in the last
week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol.
2011 22: 1478 – 1486. (IF 6,452)
148.
Knudsen AK, Brunelli C, Kaasa S, Apolone G, Corli O, Montanari M, Fainsinger R, Aass
N, Fayers P, Caraceni A, Klepstad P; European Palliative Care Research Collaborative; European
Pharmacogenetic Study. Which variables are associated with pain intensity and treatment
response in advanced cancer patients?--Implications for a future classification system for cancer
pain. Eur J Pain. 2011 Mar;15(3):320-7. (IF 3,819)
149.
Pigni A, Brunelli C, Caraceni A. The role of hydromorphone in cancer pain treatment: A
systematic review. Palliative Medicine, in press (IF 2,515)
150.
Caraceni A, Pigni A, Brunelli C. Is oral morphine still the first choice opioid for moderate
to severe cancer pain? A systematic review within the European Palliative Care Research
Collaborative Guidelines Project. Palliative Medicine, in press (IF 2,515)
11
151.
Radbruch L., Radbruch L, Trottenberg P, Elsner F, Kaasa S and Caraceni A. Asystematic
review on the role of alternative application routes for opioid treatment for moderate to severe
cancer pain: An EPCRC opioid guidelines project. Palliative Medicine, in press (IF 2,515)
152.
Mercadante S, Caraceni A Conversion ratios for opioid switching for the treatment of
cancer pain: EAPC Research Network recommendations.Palliative Medicine in press (IF 2,515)
153.
Kaasa S Apolone G, Klepstad P, Loge JH, Hjermstad M, Corli O, Strasser F, Heiskanen
T, Costantini M, Zagonel V, Groenvold M., Fainsinger R, Jensen MP, Farrar JT, Mcquay, H,
Rothrock N, Cleary J, Deguines C., Caraceni A , European Palliative care Collaborative (EPCRC)
and the European Association for Palliative Care Research Network (EAPC RN) Expert
conference in cancer pain assessment and classification the need for international consensus:
working proposals on international standards BMJ Supportive and Palliative care 1: 3: 281-287
2011
154.
Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F,
Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M,
Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D,
Zeppetella G; European Palliative Care Research Collaborative (EPCRC); European Association
for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidencebased recommendations from the EAPC. Lancet Oncol. 2012 Feb;13(2):e58-68.
155.
Caraceni A, Bertetto O, Labianca R, Maltoni M, Mercadante S, Varrassi G, Zaninetta G,
Zucco F, Bagnasco M, Lanata L, De Conno F, on Behalf of the Breakthrough/Episodic Pain Italian
Study Group Episodic (breakthrough) pain prevalence in a population cancer pain patients.
Comparison of clinical diagnosis with the QUDEI –Italian Questionnaire for Episodic Pain Journal
Pain Sympt Manage , 2012; 43 (5) 833-841 (IF 2,640)
156.
Caraceni A, Zecca, Martini C, Gorni G, Campa T, Brunelli C, De Conno F Palliative
sedation at the end of life at a tertiary cancer centre Supportive Care in Cancer, Support Care
Cancer. 2012 Jun;20(6):1299-307. Epub 2011 Jul 16 (IF 2,089)
157.
Knudsen AK, Brunelli C, Klepstad P, Aass N, Apolone G, Corli O, Montanari M, Caraceni
A, Kaasa S.Which domains should be included in a cancer pain classification system? Analyses
of longitudinal data. Pain. 2012 Mar;153(3):696-703. Epub 2012 Jan
158.
Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role of
paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the
control of pain in advanced cancer. A systematic review of the literature. Palliat Med. 2012
Jun;26(4):305-12. Epub 2011 Nov 29
159.
Scarpi E, Maltoni M, Miceli R, Mariani L, Caraceni A, Amadori D, Nanni O. Survival
prediction for terminally ill cancer patients: revision of the palliative prognostic score with
incorporation of delirium. Oncologist. 2011;16(12):1793-9. Epub 2011 Oct 31
160.
Raijmakers NJ, van Zuylen L, Costantini M, Caraceni A, Clark JB, De Simone G,
Lundquist G, Voltz R, Ellershaw JE, van der Heide A on behalf of OPCARE9; Issues and needs in
end-of-life decision making: An international modified Delphi study. Palliat Med. 2012
Oct;26(7):947-953. Epub 2011 Oct 3.
161.
Hjermstad MJ, Lie HC, Caraceni A, Currow DC, Fainsinger RL, Gundersen OE, Haugen
DF, Heitzer E, Radbruch L, Stone PC, Strasser F, Kaasa S, Loge JH; on behalf of the European
Palliative Care Research Collaborative (EPCRC). Computer-Based Symptom Assessment Is
12
Feasible in Patients With Advanced Cancer: Results From an International Multicenter Study, the
EPCRC-CSA. J Pain Symptom Manage. 2012 Jul 13. [Epub ahead of print] 1:
162.
Corli O, Montanari M, Greco MT, Brunelli C, Kaasa S, Caraceni A, Apolone G. How to
evaluate the effect of pain treatments in cancer patients: Results from a longitudinal outcomes
and endpoint Italian cohort study. Eur J Pain. 2012 Dec 5. doi: 10.1002/j.15322149.2012.00257.x. [Epub ahead of print] PubMed PMID: 23213042.
163.
Rayment C, Hjermstad MJ, Aass N, Kaasa S, Caraceni A, Strasser F, Heitzer E,
Fainsinger R, Bennett MI; On behalf of the European Palliative Care Research Collaborative
(EPCRC). Neuropathic cancer pain: Prevalence, severity, analgesics and impact from the
European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
Palliat Med. 2012 Nov 21. [Epub ahead of print] PubMed PMID: 23175513. affiliation hospice V.
Floriani
164.
Messina G, Rizzi M, Cordella R, Caraceni A, Zecca E, Bussone G, Franzini A, Leone M.
Secondary chronic cluster headache treated by posterior hypothalamic deep brain stimulation:
First reported case. Cephalalgia. 2012 Nov 19. [Epub ahead of print] PubMed PMID: 23165695.
Pharmacogenet Genomics. 2013 Mar;23(3):117-126.
165.
Fladvad T, Klepstad P, Langaas M, Dale O, Kaasa S, Caraceni A, Skorpen F Variability in
UDP-glucuronosyltransferase genes and morphine metabolism: observations from a crosssectional multicenter study in advanced cancer patients with pain. Pharmacogenet Genomics.
2013 Mar;23(3):117-126.
Senza IMPACT FACTOR
1. Ventafridda V, Spoldi E, Caraceni A, Toscani F, De Conno F: Indicazione e limiti della
somministrazione di morfina per via sottocutanea. Algos 3: 323-329, 1986.
2. Ventafridda V., Spoldi E, Caraceni A, De Conno F: Percutaneous
modalities. Ind J Pain 1: 127-135, 1986.
cordotomy and other
3. Ventafridda V, Caraceni A, Spoldi E, Ripamonti C, Saita L, Toscani F, De Conno F: Gli oppioidi
nel dolore da cancro secondo la proposta dell'Organizzazione Mondiale della Sanita'. Algos 4:
41- 47, 1987.
4. Ventafridda V, Caraceni A, Saita L, De Conno F: WHO method for cancer pain relief. Ind J Pain
2:78-81, 1987.
5. Ventafridda V, Saita L, Oliveri E, Ripamonti C, Caraceni A et al: Somministrazione orale di
morfina in soluzione acquosa ed in compresse a lento rilascio nel dolore da cancro. Algos 5:
66-71, 1988.
6. Caraceni A: Compressioni midollari metastatiche: diagnosi e terapia. Argomenti di Oncologia 9:
45-52, 1988.
7. Ventafridda V, Spoldi E, De Conno F, Caraceni A: Trattamento farmacologico del dolore da
cancro: gli oppioidi. Argomenti di Oncologia 9: 213-221, 1988.
8. Ventafridda V, Caraceni A, Saita L, Bonezzi C, De Conno F, Gurise G, Ramella G., Silvani V,
Tamburini M, Toscani F. Trazodone for deafferentation pain. Comparison with amitriptyline.
Psychopharmacology 95: S44-S49, 1988. *
13
9. Toscani F, Camerini S, Scazzina M, Caraceni A, De Conno F, Ripamonti C, Saita L, Spoldi E,
Tamburini M, Corli O, Gallucci M. Valutazione clinica del trazodone nel trattamento del dolore
disestesico nell neoplastico avanzato. Algos 6: 21-25, 1989.
10. Pastena L, Caraceni A, Mainardi G., Gagliardi R, Faralli F, Brauzzi M, Fiorito A. Considerazioni su
un caso di iperossia documentato con EEG. Annali di Medicina Navale XCV, 508-515, 1990.
11. Pastena L, Gagliardi R, Maroni W, Brauzzi M, Caraceni A, Fiorito A, Mainardi G, Bernini Vanni P.
Nuove metodolologie di rilevamento di dati elettrofisiologici in medicina subacquea e iperbarica.
Annali di Medicina Navale XCV, 341-355, 1990
12. Da Poian SH, Caraceni A. Administracao subcutanea de Opioides. Rev Bras Anest, 41: 267-271,
1991
13. Pastena L, Mainardi G, Caraceni A, Gagliardi R, Faralli F, Bernini Vanni P. L'attivita' elettrica
cerebrale durante respirazione di ossigeno normobarico e di ossigeno a 2,8 ATA. Annali di
Medicina Navale XCVII: 37-48, 1992.
14. Pastena L, Mainardi G, Seri S, Faralli F, Caraceni A, Matarese D, Gagliardi R. Confronto
dell'attivita' elettroencefalografica durante due esperienze di saturazione (-205, -250). Giornale di
Medicina Militare 5-6: 503-513, 1992.
15. Caraceni A. Epidemiologia del dolore da cancro. Quaderni di Cure Palliative 2: 111-115, 1993.
16. Caraceni A. La terapia del dolore da cancro avanzato dalla teoria alla pratica . Quaderni di Cure
Palliative 1: 53-54, 1993.
17. Caraceni A. Multidisciplinarieta' per i sintomi neuropsichici nelle cure palliative ? Quaderni di
Cure Palliative 2: 89-90 1994.
18. Caraceni A. (a cura di) Astenia e Sintomi Neuropsicologici. Quaderni di Cure Palliative 2, 2, 1994.
19. De Conno F, Caraceni A, Ventafridda V, Aldrighetti L, Ferla G, Magnani G, Comi G. Reply to the
letter by Dr. R.B. Traycoff et al. Pain 60: 234-235, 1995. *
20.Caraceni A. Delirium in palliative medicine. Eur J Pall Care 1995; 2: 62-67.
21. Caraceni A. Portenoy R.K. Oppioidi nel trattamento del dolore cronico non maligno Quaderni di
Cure Palliative 4: 361-367, 1995
22. Ventafridda V, Caraceni A, Sbanotto A. Cancer pain management. Pain reviews 3:153-179,
1996.
23. De Conno F, Caraceni A. Terapia con oppioidi nel dolore non maligno. Algia 1: 14-17 1997
24. De Conno F, Caraceni A. Terapia antalgica step by step Algia 1: 18-19.
25. Caraceni A. Dispnea terminale. Due casi clinici, implicazioni terapeutiche ed etiche. Quaderni di
Cure Palliative 5: 250-254, 1997
26. Caraceni A. Dispnea terminale. Due casi clinici, implicazioni terapeutiche ed etiche. Quaderni di
Cure Palliative 5: 250-254, 1997
14
27. Caraceni A, De Conno F. Analgesic effects of chemotherapy ? (letter), J Clin Oncology 16: 803,
1998.
28. Caraceni A, Zecca E, Martini C, Brunelli C, Votta A, De Conno F. Analgesia controllata dal
paziente (PCA) per il controllo del dolore incidente nel paziente con cancro avanzato. Rivista
Italiana di Cure Palliative 1999
29.Caraceni A. The contribution of neurophysiology to the diagnosis of leptomeningeal metastases.
Neurol Sci 2000;21:65-66.
30. Caraceni A, Zecca E, Martini C, De Conno F. Differences in gabapentin efficacy for cancer pain
more apparent than real ? J Pain Symptom Manage 2001; 21: 93-94. letter
31.Caraceni, A. and Weinstein, S.M., Classification of cancer pain syndromes, Oncology, 15 (2001)
1627-1642.
32.Bosisio, M., Caraceni, A., Grassi, L., Borreani, C., Mercadante, S., Luzzani, M., Maltoni, M. and
Caraceni, A., Fenomenologia clinica del delirium nel paziente oncologico, Rivista Italiana di Cure
Palliative, 4 (2002) 17-30.
33. Caraceni A. Scale di Valutazione Dolore Neuropatico 2005, 1: 13-22
34. Caraceni A, Brunelli C, Martini C, Zecca E, De Conno F. Enhancing the quality of clinical trials
in cancer pain first requires that pain assessment methods are appropriately understood and
used Br J Cancer 2006 (95) 1121. letter
35. Cislaghi G.L., Brunelli C, Baiguini G, De Conno F, Caraceni A. Il trattamento professionale
Shiatsu nell’assistenza alla persona ricoverata in Hospice. Rivista Italiana di Cure Palliative
2007; 7 (2): 30-35
36.
Boffi R, Caraceni A, Portenoy R, Andersen H, Lonati G, De Conno F Attitudine di
diverse categorie di medici italiani verso gli oppioidi RICP 2001 3 (4) : 209-215
37. Caraceni A Le regole di fine vita in salsa olandese Janus 2008; 29: 60-63
38.Kaasa S., Caraceni A.: Palliative cancer care research. Editorial Palliat Med 2010; 24: 259-260
C Capitoli di libri
1) Ventafridda V, Caraceni A et al: Cancer pain and mobility. In M Tiengo et al (eds) Advances in Pain
Research and Therapy vol 10, Raven Press, New York, 1987 pp 135-146.
2) Mancia M, Mariotti M,Caraceni A et al: Center- Median Parafascicularis thalamic complex and
mediodorsal nucleus unitary responses to noxious stimuli and their conditioning by limbic and
mesencephalic stimulations. In M. Tiengo et al (eds) Advances in pain Research and Therapy vol 10,
Raven Press, New York, 1987 pp 17-29.
3) Ventafridda V, Sbanotto A,Spoldi E, Caraceni A, De Conno F: Cancer pain management and drug
delivery. In Domellof L (ed) Drug Delivery in Cancer Treatment, Spinger Verlag, Berlin, 1987 pp 3-17.
4) De Conno F, Caraceni A, Ventafridda V: Il dolore toracico e il suo trattamento sintomatico. In Ravasi G,
Preda F (eds) Manuale di Oncologia Chirurgica Toracica, Casa Editrice Ambrosiana, Milano, 1988 pp
15
281-286.
5) Caraceni A , Spoldi E: Quadri clinici oncologici particolari. In Di Mola G (ed) Cure Palliative, Masson,
Milano 1988: 73-80.
6) Ventafridda V, Caraceni A, Sbanotto A, Spoldi E, De Conno F: Analgesic drugs in palliative care, In
Domellof L (ed) Drug Delivery in Cancer Treatment II, Springer Verlag, Berlin, 1989 pp 3-13.
7) Ventafridda V, Caraceni A, Gamba A: Summary of Demonstration Projects. Field testing of the WHO
guidelines for cancer pain relief. In Foley K.M.et al Advances in Pain Research and therapy vol 16: 451 464 1990.
8) Ventafridda V, Caraceni A, Saita L, Spoldi E, De Conno F. Symptom control in palliative care. In
Domellof L (ed) Drug Delivery in Cancer Treatment III, Springer Verlag, Berlin, 1991 pp 19 -39.
9) Caraceni A, Martini C. Le funzioni cognitive. In Tamburini M (ed), La Valutazione della Qualita' di Vita
in Oncologia. Masson, Milano 1990 pp 145 - 160.
10) Ventafridda V, Saita L, Caraceni A, De Conno F. La terapia del dolore nei bambini con malattia
neoplastica. In Assael BM (ed) Fisiopatologia e Terapia in Pediatria. Congress Studio, Milano, 1990 pp.
785-795
11) Ventafridda V, Saita L, Caraceni A, De Conno F. La terapia del dolore nei bambini con malattia
neoplastica. In Assael BM (ed) Fisiopatologia e Terapia in Pediatria. II ed. Intramed Communications,
Milano 1993 pp 247-251
12) Ventafridda V, Caraceni A. Cancer Pain. In Prtvij Raj (ed). Current review on Pain. Current Medicine,
Philadelphia, 1994 pp 155-178.
13) Ventafridda V, Caraceni A, Tamburini M. Cure Palliative. In Staudacher V, Veronesi U, Andreoni B,
Costa A (Eds) Manuale di Oncologia Chirurgica III edizione, Masson, Milano, 1994 pp 195-217
14) De Conno F, Caraceni A, Ventafridda V. Principi di assistenza domiciliare. In Bonadonna G,
Robustelli della Cuna, G (eds) Medicina Oncologica, V edizione, Masson, Milano, 1994 pp 1439-1443.
15) Caraceni A, Martini C. Confusione mentale e sintomi neuropsichici nel paziente oncologico. In
Mercadante S (ed) Trattamento del dolore e dei sintomi nel cancro avanzato. Progressi Clinici: Medicina
Vol 7, n. 6, Piccin, Padova, 1995 pp 189-203.
16) Caraceni A., Martini C. Neurological Problems in Palliative Medicine. In Doyle D, MacDonald N, Hanks
G. Oxford textbook of Palliative Medicine II ed.. Oxford University Press, Oxford, 1998, pp 727-749.
17) Caraceni A, Foley K M. La douleur du cancer et les syndromes douloureux du cancer. In Brasseur L.
Chauvin M, Guilbaud G , (eds) Douleurs. Maloine, Paris, 1997 pp 567-587.
18) Caraceni A , Spoldi E: Quadri clinici oncologici particolari. In Di Mola G (ed) Cure Palliative, Masson,
Milano, 1994, pp 73-81
19) Borreani C, Caraceni A, Tamburini M. The role of counselling for the confused patient and the family.
In: Portenoy R.K., Bruera E. (Eds) Supportive Care Medicine vol 1. Oxford University Press 1997 pp 4554.
20) Ingham J.M., Caraceni A. Delirium In: Berger A., Levy M.H., Portenoy R.K., Weissman (Eds)
Principles and practice of Supportive Care in Oncology Lippincott-Raven, Philadelphia, 1998, pp 477-495
16
21) Caraceni A. Evaluation of cancer pain: multidimensional assessment and pain syndromes. In Campbel
J.N. (ed) "Pain 1996 An updated review. Refresher Course Syllabus." IASP Press, Seattle 1996 pp 219237.
22) Ceroni M, Simonetti F, Massimino M, Cefalo G, Caraceni A. I tumori cerebrali. In Amadori D, De
Conno F, Maltoni M, Working expert group on guidelines for specific medical treatment in advanced
cancer patients. Milano, UTET, 1999 pp 153-172
23) Caraceni A. Le emergenze neurologiche. In Amadori D, De Conno F, Maltoni M, Working expert group
on guidelines for specific medical treatment in advanced cancer patients. Milano, UTET, 1999 266-272
24) Caraceni A. Il dolore neuropatico nel paziente oncologico. In Buonocore M, Bonezzi C (curatori) Il
dolore neurogeno dalla definizione alla terapia. Advances in rehabilitation vol 1 n 4 Maugeri Foundation
Books, Pavia pp 121-130
25) Caraceni A, Foley F. Il dolore da cancro e le sindromi algiche neoplastiche. In In Brasseur L. Chauvin
M, Guilbaud G , (eds) Dolori. Fondamenti di base farmacologia, dolori acuti e cronici, terapie. Mediserve,
Milano, 1999 pp 567-587.
26) Cheville A, Caraceni A, Portenoy, R.K. Pain definition and assessment. In Massie J.M. (Ed) Pain.
What psychiatrists need to know. Review of Psychiatry vol 19. Washington American Psychiatric Press,
2000: 1-22.
27) Caraceni A, Cheville A, Portenoy RK. Pain management pharmacological and non-pharmacological
treatments. In: Massie JM, editor. Pain what psychiatrists need to know. Washington: American
Psychiatric Press, 2000:23-88.
28) Martini C, Caraceni A. Valutazione del dolore. In: Mercadante S, Ripamonti C, editors. Valutazione
diagnosi e trattamento del dolore da cancro. Milano: Masson, 2000:1-16.
29) Martini C, Caraceni A. Sindromi dolorose in oncologia. In: Mercadante S, Ripamonti C, editors.
Valutazione, diagnosi e trattamento del dolore da cancro. Milano: Masson, 2000:17-31.
30) Caraceni A. Le compressioni midollari metastatiche. In: Masson, editor. Valutazione, diagnosi e
terapia del dolore da cancro. Milano: Masson, 2000:156-168.
31) Caraceni A, Portenoy R.K. Pain . In Joint R and Griggs R. (eds) Baker’s Clinical Neurology. LippincottRaven Publishers, Philadelphia PA, USA, ON CD ROM
a) Edition 2003
b) Edition 2004.
32) Caraceni A, Martini C. Delirium e demenza in oncologia in Bellani, MC, Morasso, G, Amadori D, Orru’
W., Grassi L., Casali PG, Bruzzi P et al Psicooncologia. Milano , Masson 2002 pp 701-718
33) Ingham, J.M. and Caraceni, A., Delirium. In: A.M. Berger, R.K. Portenoy and D.E. Weissman (Eds.),
Principles and practice of palliative care and supportive oncology, Lippincott Williams and Wilkins,
Philadelphia, 2002, pp. 555-576.
34) Caraceni A, Bosisio M, Ingham JM. Confusion and delirium In Schiff D. Wen PY (eds)
Cancer Neurology in clinical practice. Totowa Humana Press 2002
35) Caraceni A., Bosisio M Acute confusional state. In Voltz R, Bernat JL, Borasio GD, Maddocks I,
Oliver D, RK Portenoy Pallitive Care in Neurology Oxford, Oxford University Press 2004 pp 228-240.
17
36) Grassi L., Caraceni A Delirium in Lelli G (Ed) Sintomi segnale in oncologia clinica. Monduzzi Editore,
Ferrara 2005 pp 335-341.
37) Caraceni A, Martini C, Simonetti F. Neurological problems in advanced cancer. In Doyle D, Hanks G.,
Cherny N., Calman K. Oxford Textbook of Palliative Care. Oxford University Press, Oxford pp 702-726.
38) Caraceni A, Martini C, Zecca E. Terapia del dolore In Bonadonna G, Robustelli Della Cuna G,
Valagussa P Medicina oncologica 8° Edizione Elsevier Masson Milano 2007 pp 1881-1898
39) Caraceni A, Grond S. The development of the WHO analgesic ladder In Forbes K (ed.) Opioids in
cancer pain Oxford pain management library Oxford University Press Oxford 2007 pp 19-24
40) Caraceni A, Bosisio M, Ingham JM. Confusion and delirium In Schiff D. Wen PY (eds)
Cancer Neurology in clinical practice II edition. Totowa Humana Press 2008 pp 65-90
41) Caraceni A, Matini C, Zecca E. La Misurazione del dolore. In Mercadante S. Il dolore valutazione,
diagnosi e trattamento. Masson, Milano 2006 pp 65-76
42) Caraceni A, Martini C, Zecca E. Dolore neuropatico. Terapia basata sull’evidenza. In Sghilanzoni A et
al Terapia delle malattie neurologiche con principi di diagnosi. Edi Ermes , Milano 2004 pp. 299-308
43) Maltoni M, Caraceni AT, Modonesi C. Prognostic indicators of survival In Bruera E, Higginson IJ,
Ripamonti C, von Gunten CF. (eds.) Textbook of palliative medicine Hodder Arnold , London 2006 pp 965975
44) Simonetti F, Caraceni AT Seizures In Prognostic indicators of survival In Bruera E, Higginson IJ,
Ripamonti C, von Gunten CF. (eds.) Textbook of palliative medicine Hodder Arnold , London 2006 pp 841848
45) Caraceni A, Martini C, Simonetti F. Neurological problems in advanced cancer. In Hanks G.,IV
edition. Oxford University Press, Oxford 2010 pp 1034-1058
46) Faskvag Haugen D, Nauck F, Caraceni A. The core team and the extended team In Hanks G.,
Cherny N., Christakis N, Fallon M, Kaasa S, Portenoy R. Oxford Textbook of Palliative Care IV edition.
Oxford University Press, Oxford 2010 pp 167-176
47) Caraceni A, Martini C, Zecca E. Cancer pain management and palliative care in Grisold W. Soffietti R
(Eds) Neurooncology , Handbook of Clinical Neurology 3rd Edition Elsevier Handb Clin Neurol.
2012;104:391-415.
.
48) Licitra L, Vermorken JB, Specenier P. Caraceni A Systemic therapy i nthe treatment of recurrent and
metastatic head and neck carcinoma In Mehanna, HM and Kina Ang K. (eds) Head and neck cancer
recurrence Thieme Stuttgart New York 2012 pp
Monografie/libri
1) Gamba A, Caraceni A.T. Le scale analogiche visive. VAS - visual analogue scales, LASA -Linear
analogue self assessment. EdiSES, Napoli, 1992.
18
2) Caraceni A, Spoldi E, De Conno F. l'infusione sottocutanea continua per il controllo del dolore e di altri
sintomi nel paziente con cancro avanzato. Pharmacia ®
3) De Conno F., Caraceni A. Manual of Cancer Pain. Kluwer Academic Publisher, Dordrecht 1996.
4) De Conno F. Caraceni A. Dolore da cancro. Un manuale pratico. Raffaello Cortina, Milano 1997.
5) Attal, N. Nicholson B, Serra J. (Eds), Baron R, Caraceni A, Glynn C., Harden N., Rowbotham, D.,
Sjolund, B. (Contributing Faculty) New Directions in Neuropathic Pain. London Royal Society of Medicine
Press, 2000.
6) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2002 volune I Dolore oncologico
Milano Elsevier, 2002
7) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2002 volune II Dolore oncologico
Milano Elsevier, 2002
8) Caraceni A, Grassi L. Delirium – Acute confusional states in palliative medicine. Oxford, Oxford
University Press 2003
9) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2003 Dolore oncologico Farmaci
per il controllo del dolore neuropatico in oncologia Milano Elsevier, 2003
10) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2004 Dolore oncologico Diagnosi
e valutazione del dolore neuropatico in oncologia Milano Elsevier, 2004
11) Caraceni A, Martini C, Zecca E. Contro il dolore Stato dell’Arte Anno 2005 Dolore oncologico.
Sindrome dolorosa dal lesione del nervo intercostobrachiale dopo chirurgia per tumore della mammella
Milano Elsevier, 2005
12) Caraceni A., Sghirlanzoni A., Simonetti F. Le complicazioni neurologiche in oncologia Springer-Verlag,
Milano 2006
13) Walsh D. Caraceni A, Fainsinger R, Foley F , Glare P, Goh C, Lloyd-Williams M. Nunez Olarte JM,
Radbruch L Palliative Medicine Saunders Elsevier, Philadelphia 2008
14) Caraceni A, Grassi L Delirum. Acute confusional states in palliative medicine 2nd edition. Oxford
University Press, Oxford 2011
19